2023788-19-2Tirzepatide 9107463-68-2Semaglutide 2381089-8-32 121062-08-6

Ernakulam, Baláže
12th Mar, 2025
Views: 2
Description:

Tirzepatide is a novel drug developed by Eli Lilly and Company, primarily targeting the GIP (glucose dependent insulinotropic polypeptide) receptor and GLP

Contact Information
Location 9796, Baláže, Ernakulam
Phone 97961694
Email liq134763@gmail.com